catalyst

A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic A — primary completion

as of 2026-07-01
at a glance
2018-07-31 · ActualThis event happened.
Synthesized from structured facts only — each point cited above.

Event

What
A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic A — primary completion
Type
Trial Readout
Date
2018-07-31
Date type
ACTUAL
Phase
Phase 2
This event happened.